Friday, 31 August 2018

Bathroom and Toilet Assist Devices Market Will Increase at a CAGR of 6.2% During 2018-2025: Grand View Research Inc.


The global bathroom and toilet assist devices market size is expected to reach USD 6.0 billion by 2025 at a 6.2% CAGR, according to a new report by Grand View Research, Inc. Growth in prevalence of chronic diseases, coupled with aging population, has resulted in a rise in individuals with various disabilities. This has significantly driven the global market.

Aging demographics has created a demand for old-age homes and long-term care centers, both of which drive demand for bathroom and toilet assist devices. In addition, rising disposable income and government support toward home healthcare is supporting market growth.
On the other hand, longer product life cycle is primarily challenging the growth of the market. In addition, reusability of these devices is restraining revenue generation. However, growth in demand for these devices is predicted to lower the effect of the above-mentioned factors. 

Access Research Report of Bathroom and Toilet Assist Devices Market @:

Further key findings from the report suggest:
·       Commodes emerged as the largest product segment as a result of the many benefits offered such as improved adjustability, enhanced ease, and flap on seats
·       Bath lifts and aids form the fastest growing segment owing to increase in number of patients with spinal injuries, which has spurred demand for various forms of mobility assist devices
·       North America dominated the market in terms of revenue in 2016. Improved awareness regarding commercially available assist devices and increasing disposable income are propelling revenue generation in the region
·       Europe is projected to witness swift growth during the forecast period owing to speedy adoption of advanced bathroom and toilet assist devices for patients with disabilities, to facilitate and reduce mobility issues
·       Key players include ArjoHuntleigh; Medical Device Depot; Carex Health Brands; Juvo Solutions; Bischoff & Bischoff GmbH; Invacare Corporation; Prism Medical; Sunrise Medical LLC; and GF Health Products, Inc.
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global bathroom and toilet assist devices market on the basis of product and region:
Bathroom and Toilet Assist Devices Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Shower Chairs and Stools
o    Shower Chairs
o    Shower Stools
o    Others
·         Bath Lifts
o    Fixed Bath Lifts
o    Reclining Bath Lifts
o    Lying Bath Lifts
o    Others
·         Toilet Seat Raisers
·         Commodes
o    Shower and Toilet Commodes
o    Toilet Commodes
·         Handgrips and Grab Bars
·         Bath Aids
Bathroom and Toilet Assist Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    U.K.
o    Germany
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa
Access Press Release of Bathroom and Toilet Assist Devices Market@: www.grandviewresearch.com/press-release/global-bathroom-toilet-assist-devices-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Drug Discovery Outsourcing Market will reach at a CAGR of 8.14% from 2018- 2025: Grand View Research Inc.


The global drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR, according to a new report by Grand View Research, Inc. Urging need to identify potential drug candidates for various chronic diseases is anticipated to fuel growth.

Technological advances in in silico drug designing and accelerating integration of Artificial Intelligence (AI) in drug discovery are driving industry progress. Multiple applications of AI algorithms in drug design and discovery provide opportunities for players to offer specialized drug discovery services. It is useful for processes such as target and compound selection, predictive analytics, screening, and drug repurposing.

Projected rise in adoption of outsourcing over the forecast period is expected to boost market revenue generation. Half of the drug discovery processes are anticipated to be outsourced, thereby creating massive opportunities for CROs, CMOs, and CDMOs to expand their market presence.
Number of collaborations among these organizations, key pharmaceutical players, and several universities has increased over the past few years. This rise in alliance further supports the projected increase in growth potential.
High cost and high risk of drug failure are major challenges faced in drug discovery. However, advances in technology that increase efficiency of drug discovery, coupled with increased adoption of highly advanced technology to provide specialized services, allow outsourcing companies to overcome these challenges.
Access Research Report of Drug Discovery Outsourcing Market@:

Further key findings from the report suggest:
·       Escalating incidence of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is projected to indirectly propel market growth. Advancements in technologies, such as emergence of Artificial Intelligence (AI) in the pharmaceutical industry, is also anticipated to accelerate industry progress
·       Moreover, increasing incidences of antibiotic resistance as well as drug resistance have improved focus on discovery of novel compounds to treat conditions such as Multidrug-Resistant TB (MDR-TB)
·       Based on workflow, lead identification and candidate optimization is slated for impressive growth owing to high bottlenecks in this workflow segment
·       By therapeutic area, oncology drug discovery outsourcing is fueled by increasing demand for oncology solutions, coupled with expanding government support in cancer research
·       North America dominates the global market owing to high focus on R&D in identification of novel drug candidates, along with presence of key players
·       Asia Pacific is projected to witness the fastest growth over the forecast period as a result of increasing number of CRO, CMOs, and CDMOs in emerging countries. Rising trend of outsourcing manufacturing and R&D activities to countries such as China and India will aid growth in the region
·       Some of the major players are Charles River; EVOTEC, Laboratory Corporation of America Holdings; GenScript, Merck & Co., Inc.; Jubilant Biosys; Thermo Fisher Scientific, Inc.; Oncodesign; Albany Molecular Research, Inc.; WuXi AppTec; Dalton Pharma Services; Pharmaceutical Product Development, LLC; DiscoverX Corporation; and QIAGEN
·       Collaboration of players with key pharmaceutical companies and academics and research centers is observed to increase in recent years.
Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global drug discovery outsourcing market on the basis of workflow, therapeutic area, drug type, and region:
Drug Discovery Outsourcing Workflow Outlook (Revenue, USD Million, 2013 - 2025)
·         Target Identification & Screening
·         Target Validation & Functional Informatics
·         Lead Identification & Candidate Optimization
·         Preclinical Development
·         Other Associated Workflow
Drug Discovery Outsourcing Therapeutic Area Outlook (Revenue, USD Million, 2013 - 2025)
·         Respiratory System
·         Pain and Anesthesia
·         Oncology
·         Ophthalmology
·         Hematology
·         Cardiovascular
·         Endocrine
·         Gastrointestinal
·         Immunomodulation
·         Anti-Infective
·         Central Nervous System
·         Dermatology
·         Genitourinary System
Drug Discovery Outsourcing Drug Type Outlook (Revenue, USD Million, 2013 - 2025)
·         Small Molecules
·         Large Molecules (Biopharmaceuticals)
Drug Discovery Outsourcing Regional Outlook (Revenue, USD Million, 2013 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
·         Middle East and Africa (MEA)
o    South Africa
Access Press Release of Drug Discovery Outsourcing Market@: www.grandviewresearch.com/press-release/global-drug-discovery-outsourcing-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Elemental Analysis Market Will hit at a CAGR of 6.2% in terms of revenues from 2018 to 2025: Grand View Research Inc.


The global elemental analysis market is expected to reach USD 2.02 billion by 2025, growing at a CAGR of 6.2%, according to a new report by Grand View Research, Inc. The market is primarily driven by amendments in the ICH (International Council for Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use) regulations that mandate use of elemental analysis for finished medical products, including pharmaceuticals.

Many manufacturers of elemental analyzers invest in R&D of new and technologically advanced products. In addition to their expenses for R&D, many key players launched new products in the market in the past 3 years. For instance, in May 2016, Agilent Technologies launched Agilent 5110 ICP-OES, which was designed to enable scientists perform fast and precise elemental analysis of pharmaceuticals and food products along with mining, industrial, and environmental analysis.
In addition, in many countries, the limit of heavy metals/trace elements is regulated by their respective pharmacopeias. For instance, United States, Japanese, and European pharmacopeias limit the amount of trace elements in finished pharmaceutical products. Furthermore, elemental analysis is a crucial step before commercial launch of a medical product in the market.
North America held the largest market share in 2016. Local presence of large number of manufacturers, regulation of limits of trace elements/heavy metals by United States Pharmacopeia (USP), and ongoing research for development of new products are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. Rise in interest of market players to expand their business in Asia Pacific, growing awareness on safety of pharmaceuticals, and increase in expenditure by local pharmaceutical companies on elemental analyzers are factors that can be attributed for the highest growth rate of Asia Pacific region during the forecast period.
Access Research Report of Elemental Analysis Market@:

Further Key Findings From the Report Suggest:
·       The inorganic elements segment held the largest revenue share in 2016 due upcoming mandates for elemental analysis in medical products
·       Nondestructive technologies held the largest revenue share of the market, by technology, in 2016. Retention of sample after analysis and high precision rate can be the key factors for largest share of this segment
·       North America dominated the global market due to presence of USP regulations that limit the amount of heavy metals/trace elements
·        Some of the key players arePerkinElmer, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; Shimadzu Corporation; and Analytik Jena AG; among others

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research, Inc. has segmented the elemental analysis market on the basis of type of elements analyzed, technologies used, and region:
Elemental Analysis Type of Elements Outlook (Revenue, USD Million, 2014 - 2025)
·         Organic Elements
·         Inorganic Elements
Elemental Analysis Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         Destructive Technologies
o    ICP-MS
o    ICP-OES
o    Combustion Analysis
o    Other destructive technologies
·         Nondestructive Technologies
o    XRF
o    FTIR
o    Other nondestructive technologies
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa
Access Press Release of Elemental Analysis Market @: www.grandviewresearch.com/press-release/global-elemental-analysis-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Fetal Monitoring Equipment Market is Thriving $6.16 Billion Revenue by 2030: Grand View Research Inc.

  Fetal Monitoring Equipment Market Growth & Trends The global  fetal monitoring equipment market  size is anticipated to reach USD 6.16...